ISSN : 0970 - 020X, ONLINE ISSN : 2231-5039
     FacebookTwitterLinkedinMendeley

Composition of Volatile Oil and Methanolic Extract of Jordanian Melissa Officinals L. and Actions Againsthuman Cancer Cell Lines

Salem A. Barakat1, M. Hudaib2, Noor EL-asadand2 and D. T. Burns3

1Department of Chemistry.Jordan University   of Science and Technology, 22110 Irbid Jordan.

2Department of Pharmacy(b), Jordan University, Jordan.

3The Institute of Global Food Security, The Queen’s University of Belfast, Belfast, BT9 5HN, Northern Ireland, United Kingdom.

Corresponding Author E-mail: Barakat@just.edu.jo

DOI : http://dx.doi.org/10.13005/ojc/320506

Article Publishing History
Article Received on :
Article Accepted on :
Article Metrics
ABSTRACT:

The essential oil of Jordanian  MelissaofficinalisL. were obtained by hydro-distillation and analyzed by Gas Chromatography – Mass Spectrometry. Components representing 96.40%  of the total oil were identified. The methanolic extract and the volatile oil of Melissa officinalisL, were tested and showed anti-proliferation activities against 3 cancer cell lines.

KEYWORDS:

Melissa officinalis. Methanolic extract, GC-MS

Download this article as: 

Copy the following to cite this article:

Barakat S. A, Hudaib M, EL-asadand N, Burns D. T. Composition of Volatile Oil and Methanolic Extract of Jordanian Melissa Officinals L. and Actions Againsthuman Cancer Cell Lines. Orient J Chem 2016;32(5).


Copy the following to cite this URL:

Barakat S. A, Hudaib M, EL-asadand N, Burns D. T. Composition of Volatile Oil and Methanolic Extract of Jordanian Melissa Officinals L. and Actions Againsthuman Cancer Cell Lines. Orient J Chem 2016;32(5). Available from: http://www.orientjchem.org/?p=21750


Introduction

Most people living in less developed countries rely almost exclusively on traditional medicines for their healthcare needs. In Jordan also many people use herbal medicines as alternative, additional or complementary medicine [1-2]. However, most of the plants used in traditional medicine in Jordan lack detailed phytochemical study and  biological evaluation [3].

One of the most interesting medicinal plant species in Jordan is Melissa, a genus of the madder family Labiatae [4]. It is widely cultivated in Europe and the United States [5].There has been considerable interest in the biological effects of essential oils from a variety of plants [6] and in their antimicrobial [7] and antioxidant properties [7-9]. The content and composition of the oil Melissa officinalisvary with its origin within a given country [10], from country to country [11-13], and under the influence of nitrogenous fertilizers [14] and growth regulators [15]. This variability increases the importance of the study of a wide range of Melissa samples.    In addition to themelissa essential oil composition, the aromatic and polyphenolic composition of herbal tea made from lemon balm (Melissa) has been reported [16].

Malissa has traditionally been used to treat a wide range of conditions such as fever, flatulence, headache, influenza and toothache [2, 5]. Numerous specific biochemical activities have been reported [17] such as acetylcholinesterase inhibition and antioxidant activity [18] and its use for the treatment of cancer [19, 20] and of diabetes [21] have been evaluated.

Milessa occurs rarely in Jordan but is found in restricted regions at WadiRajeb. It is a neglected, underutilized plant and threatened by wild herbs. Preliminary work was carried out by Syouf with collections from 3, not previously, studied sites in Jordan [22] the locations are shown in Table 1-1.

Table 1: Collection of wild Melissa officinalisfrom 3 sites in Jordan, with GIS data.

Longitude E

Latitude N

Elevation

JO. NO.

Collection location

Number

35 41  50.0

32 18 23.5

506

3098

Kufrangeh

1

35 41 54.1

32 14 31.5

300

3099

WadiRajib

2

35 41.33.3

32 13 59.5

418

3100

Rajib ( Al Tal)

3

 

The essential oil composition of Melissa from Jordan and its anti-cancer proliferative activity have not been studied previously. Here in the analysis of the essential oil from these Melissa species is described for the first time.

Material and Method

 Plant materials

A large sample of wild Melissa officinalis SP were collected in Jordan in 2011.  The plants were identified by Dr. Maha Al- Syuof. (Biodiversity department, NCARE[22]) .The aerial parts of the plants were dried at room temperature and then coarsely powdered.

 Extraction, isolation and identification of the essential oil

Dried leaves of M. officinaliswere subjected to hydrodistillation for 3 hours using

a Clevenger type apparatus [23]. The oil was collected, dried over anhydrous sodium sulphate and stored in the dark in a refrigerator until analyzed.

 Gas Chromatographic – Mass Spectral (GC-MS) Analysis

About 1 μl aliquot of each oil sample, diluted in n-hexane, was subjected to GC-MS analysis. GC-MS analysis was performed using a Varian Chrompack CP-3800 GC/MS/MS-200 (Saturn, Netherlands) equipped with split-splitless injector and DB-5 (5% diphenyl, 95% dimethylpolysiloxane) capillary GC column (30m x 0.25mm ID, 0.25 μl film thickness). The carrier (ultra-pure helium) flow rate was 1ml/min. The column temperature was kept at 100ᵒC for 3 min and then programmed  at rate of 10ᵒC/min up to 250ᵒC, and then held at 250ᵒC for 60 min. The total run time was 56.98 min the mass detector was set to scan ion between 35-500 m/z. A mixture of n-alkanes (C8-C20) was analyzed separately under the same conditions using the same DB-5 column. The compounds in the volatile oil  s were identified, using built in libraries (NIST Co and Wiley Co, USa)

Identification of the compounds

The compounds were identified by comparing the retention time, retention index and mass spectrum of the chromatographic peaks with that of the standardsavailable .

The identification of other  components was by computer matching with the Wiley, NIST and ADAMS libraries [24] based on their retention indices [25] determined by reference to a homologous series of n-alkanes, (C8-C20) and by comparison of their mass spectral fragmentation patterns with those reported in the literature [24] and stored on the MS library data system.  Using the van den Dool equation [26], to get RI values  helps by predicting the closet component from the top ten component summary which are given from the data system.

Vol32No5_COMP_Sale_f1

tx = retention time of unknown component

tn = retention time of preceding n-alkane

t(n+1) = retention time of following n-alkane

n = carbon number of preceding n-alkane

RI: arithmetic index as reported in literature .

KI: Kováts index as reported in literature .

Results

In the Table(1-2).which follow  the major oil components (component  %>3) are indicated in bold.

Table 2: the chemical composition for the volatile oil of Melissa officinalis SP.

No

Rt

Content

AI

KI

Compounds

MEL98R22 LEV

1

10.523

0.513

1044

1050

<(E)-B>OCIMENE

2

13.956

0.109

1122

1126

<alpha->Campholenal

3

15.567

0.331

1160

1164

Pinocarvone

4

16.320

1.659

1174

1177

Terpinen-4-ol

5

19.149

0.331

1238

1241

Cumin aldehyde

6

21.323

0.010

1289

1290

Thymol

7

22.899

0.401

1325

1327

<p->Mentha-1,4-diene-7-ol

8

24.653

2.516

1374

1376

<alpha->copaene

9

24.999

3.141

1387

1388

<beta->Bourbonene

10

25.225

2.724

1381

1382

Panasinsene

11

26.572

3.417

1417

1419

<(E)->Caryophellene

12

28.053

1.931

1449

1415

Amorpha-4,11-diene

13

29.089

28.847

1478

1479

<Gamma->Muurolene

14

31.850

3.530

1548

1549

Elemol

15

33.166

43.556

1582

1583

Caryophellene Oxide

16

34.128

2.006

1608

1608

Humulene epoxide II

17

36.435

1.431

1680

1680

Elemol acetate

18

42.000

2.471

disappear

MEL98R22 ST

1

10.557

0.1

1044

1050

<(E)-B>OCIMENE

2

12.183

0.1

1086

1088

<alpha->Terpinolene

3

14.551

0.2

1135

1139

<trans->pinocarveol

4

15.367

trace

1160

1164

<cis->Chrysanthenol

5

16.321

0.3

1174

1177

Terpinen-4-ol

6

19.126

trace

1238

1241

Cumin aldehyde

7

20.428

trace

1264

1267

E-citral

8

21.309

trace

1298

1299

Carvacrol

9

22.496

0.2

1315

1316

<(2E,4E)->Decadienal

10

24.648

2.1

1374

1376

<alpha->copaene

11

24.998

2.0

1387

1388

<beta->Bourbonene

12

25.221

20.9

1381

1382

Panasinsene

13

26.508

15.8

1417

1419

<(E)->Caryophellene

14

28.047

4.5

1449

1415

Amorpha-4,11-diene

15

29.023

22.2

1478

1479

<Gamma->Muurolene

16

31.847

trace

1548

1549

Elemol

17

33.060

30.5

1582

1583

Caryophellene Oxide

18

41.041

0.2

1800

1800

isotorquatone

19

42.409

0.4

Unkown

Normal Monoterpenes

0.2%

Oxygenated Monoterpenes

2.6%

Normal sesquiterpenes

39.1%

Oxygenated sesquiterpenes

53.9%

 

Table 3: Major component in Melissa officinalissp         

98R22 Leaf   Major Compound

%Content >3

1

<(E)->Caryophellene

3.4

2

<beta->Bourbonene

3.1

3

<Gamma->Muurolene

28.8

4

Elemol

3.530

5

Caryophellene Oxide

43.556

98R22 Stem

Major Compound

Content >3%

1

Panasinsene

20.9

2

<(E)->Caryophellene

15.8

3

Amorpha-4,11-diene

4.5

4

<Gamma->Muurolene

22.2

5

Caryophellene Oxide

30.5

The total amount content was 0.1 ml.

The Chemical composition of  Melissaofficinalis from WadiRujb /Ajlun is shown in Table 1-4.

Table 4: Chemical composition of  Melissaofficinalis SP WadiRujb /Ajlun. 

The amount of oil collected was 0.2 ml.

No

Rt 

Content 

 AI

KI 

MEL99R31LEV

1

10.112

0.1

1032

1037

<(Z)-B>Ocimene

2

14.568

0.1

1137

1142

<trans->Sabinol trans for OH vs IPP

3

15.408

0.1

1160

1164

Pinocarvone

4

16.337

0.1

1174

1177

Terpinen-4-ol

5

18.821

1.6

1235

1238

Neral

6

20.119

2.6

1160

1164

<(Z)->Isocitral

7

24.642

3.1

1374

1376

<alpha->copaene

8

24.986

3.2

1387

1388

<beta->Bourbonene

9

25.148

1.1

1389

1390

<Gamma->Elemene

10

26.510

16.4

1417

1419

<(E)->Caryophellene

11

28.037

4.3

1449

1451

Amorpha-4,11-diene

12

29.030

19.9

1478

1479

<Gamma->Muurolene

13

31.841

2.4

1548

1549

Elemol

14

33.092

39.8

1582

1583

Caryophyllene Oxide

15

34.112

1.7

1608

1608

Humulene epoxide II

16

36.425

2.3

1668

1669

<(Z)->Caryophyllene<14-hydroxy-9-EPI

17

42.261

0.1

Unkown

MEL99R31ST

1

10.559

0.0

1044

1050

<(E)-Beta->Ocimene

2

12.744

0.1

3-methyl-2-(2-methyl-2-butenyl)-furan

3

14.660

0.1

1137

1142

<trans->Sabinol trans for OH vs IPP

4

15.445

0.1

1160

1164

Pinocarvone

5

16.280

0.3

1174

1177

Terpinen-4-ol

6

19.564

0.1

1238

1241

Cumin aldehyde

7

20.477

6.7

1264

1267

E-citral

8

21.486

4.2

1299

1299

<cis-α ->Necrodol acetate

9

24.983

3.8

1387

1388

<beta->Bourbonene

10

25.523

2.2

1389

1390

<Gamma->Elemene

11

26.493

15.6

1417

1419

<(E)->Caryophellene

12

28.003

4.3

1449

1451

Amorpha-4,11-diene

13

29.003

17.4

1478

1479

<Gamma->Muurolene

14

33.040

42.6

1582

1583

Caryophyllene Oxide

15

36.523

1.9

1668

1669

<(Z)->Caryophyllene<14-hydroxy-9-EPI

16

41.035

0.1

1800

1800

Isotorqutone

17

42.238

0.5

Unkown

Normal Monoterpenes

3.2%

Oxygenated Monoterpenes

4.3%

Normal Sesquiterpenes

48%

Oxygenated Sesquiterpenes

46.3%

 

The amount of oil collected was 0.2 ml.

Table 5: Major Components  in the Mellissa officinalis SP

99R31Leaf

Major compounds

% Content>3

1

< α->copaene

3.1

2

<β ->Bourbonene

3.2

3

<(E)->Caryophellene

16.4

4

Amorpha-4,11-diene

4.3

5

<γ ->Muurolene

19.9

6

Caryophyllene Oxide

39.8

99R31 Stem

Major compounds

% Content>3

1

E-citral

6.7

2

<cis-α ->Necrodol acetate

4.2

3

<β ->Bourbonene

3.8

4

<(E)->Caryophellene

15.6

5

Amorpha-4,11-diene

4.3

6

<γ ->Muurolene

17.4

7

Caryophyllene Oxide

42.6

 

Antiproliferative Activity Against Human Cancer Cell Lines

The methanolic extractof Melissa officinalis SP was tested on three cancer cell lines namely : two types of colorectal (SW480), (HCT116), and prostate (PC3).As were the volatile oils of the  plants.

These cancer cell lines were treated with different concentration of  plant extract

( 10µg/ml,25 µg/ml,50 µg/ml,100 µg/ml), and  for the  volatile oil   (1 µg/ml,1.5 µg/ml,5 µg/ml, 10 µg/ml) , for 72 hr.

The cells growth were evaluated using MTT assay as illustrated in below.

Table 6: IC50 for Melissa officinals SP methanolic extract.

 

SW480

HCT116

PC3

0

100

100

100

10

100

100

100

25

100

100

100

50

85.51449

100

100

100

60.43956

69.11142

94.47674

IC50

130.2

180.68

H

0.9459

0.7776

Table 7: IC50 for Melissa officinalis SP volatile oil.

 

SW480

HCT116

PC3

0

100

100

100

1

86.95652

100

100

2.5

80.43478

100

100

5

67.3913

100

100

10

67

100

100

IC50

13.67

H

H

R2

0.745

 

Figure 1: IC50 effect of the plant volatile oils.

Figure 1: IC50 effect of the plant volatile oils.


Click here to View Figure

 

Table 8: IC50 (µg/mL) of different plant fractions against different cancer cell line.

 

SW40

HCT116

PC3

Cultivated V. Oil

114

H

H

Wild V. Oil

13.67

H

H

Cultivated Crud Ext.

135

229

199.7

Wild Crud Ext.

130.2

180.68

H

Conclusion

Herein is reported the chemical composition of the volatile oils obtained by hydrodistillation  from the two Melissa species, The  plant also evaluated for its anti-proliferative activities using (SW480), (HCT116), and (PC3) , cancer cell lines. Results revealed that the methanolic extract of Mellissa officinalshasan effect  in cell viability. Further studies are needed for determination of the mode of action(s) of these plants  antiproliferative activities.

The present study strengthen  evidence that the search for new anti cancer agent should emphasize to the screening of natural flora of the different countries.

It can be noticed generally that the chemical composition of JordanianMellissa officinlis sp ,and Mellissa officinalisin other countries have not   identical components .

The composition of the oil from M. officinalis harvested in Algeria was dominated by

neral, geranial and citronellal. This composition was qualitatively the same that the oilsfrom Serbia (Dukic et al., 2004), Slovak [22], Egypt (Shalaby El-

Gengaihi and Khattab, 1995), France (Carnatet al., 1998) and Iran (Sadraei et al., 2003);

However, limonene was the major component in the samples from

Scotland (Damien et al., 2000) (57.5 %), neral was found with only (4.3 %) and geranial

was completely absent. Basta et al. (2005) reported that caryophyllene oxide (12.6 %) and β-pinene (18.2 %) were also the most abundant constituents in the oil of M. officinalisfrom Greece but neral and geranial were not detected in the oil. Oils from Cuba [13]) and Brazil [15] were dominated by neral (29.9 % and39.3 %) and geranial (41.0 % and 47.3 %) respectively.

Which clearly leads to conclusion that the chemical composition of the plantand volatile oil composition may vary according to location.

Aknowledgement

The authors aknowledge Highercounceil at Jordan University of Science& Technology for Financial support.

References 

  1. Balunas M. J. and Kingborn, A. D. Drug discovery from medicinal plants. Life sciences.(2005).  78, 431-441.
  2.  Al-Khalil S. A survey of Plants Used in Jordanian Traditional Medicine. Int. J. of Pharmacog.,(1995). 33, 317-323.
  3.  Al-Eisawi D. M. H. Field Guide to Wild Flowers of Jordan and Neighbouring Countries. Jordan Press Foundation “AL RAI”, Amman, Jordan. . (1998)
  4. Feinbrun-Dothan N. in M. Zohary and N. Feinbrun-Dothan, (eds). Flora Palaestina, Part3. Israel Academy of Sciences And Humanities, Jerusalem,  Pp.146-147
  5. Moradkhani H. et alia. Melissa officinals L., a valuable medicine plantA review. J. Med. Plants Res., (2010)4, 2753-2759.
  6. Bakkali F., Averbeck S., Averbeck D. and Idaomar M. Biological effects of essential oils-A review, Food Chem. Toxicol.,(2008). 46, 446-475.
  7.  Mimica-Dukic N., Bozin B., Sokovic M. and Simin N. Antimicrobial and antioxidant activities of Melissa officinalis L. (Lamiaceae) essential oil. J. Agric. Food Chem., (2004) 52, 2485-2489.
  8. Dorman H. J. D., Surai P. and Deans S. G., In Vitro antioxidant activity of plant essential oils and phytoconstituents, J. Essent. Oil Res.,(2000)12, 241-248.
  9. Koksal E., Bursal E., Dikici E., Tozoglu F. and Gulcin I. Antioxidant activity of Melissa officinalis leaves, J. Medic. Plants Res.,(2011). 5, 217-222.
  10.  Patora J., Majda T., Góra J. and Klimek   B. Variability in the content and composition of essential oil from lemon balm (Melissa officinalis L.) cultivated in Poland. Acta Polonia Pharma.,(2003).  60, 395-400.
  11. Sari A. O., and Ceylan A. Yield characteristics and essential oil composition of Lemon Balm (Melissa officinalis L.) grown in the Aegean region of Turkey. Turk. J. Agric For.,(2002). 26, 217-224.
  12. Hollá M. et alia Composition of the essential oil from Melissaofficinalis L. cultivated in Slovak Republic, J. Essent. Oil Res.,(1997). 9, 481-484.
  13. Pino J. O., Rosado A. and Fuentes V. Composition of the essential oil of Melissa officinalis L. from Cuba, J. Essent. Oil Res., (1999).11, 363-364.
  14. Abbaszadeh B., Farahani H. A., Valadabadi S. A. and Darvishi H.H. Nitogenous fertilizer influence on quantity and quality values of balm (Melissa officinalis L.), J. Agric. Ext. Rural Dev.(2009), 1, 31-33
  15. Da Silva S. et alia Essential oil composition of Melissa officinalis L. in vitro produced under the influence of growth regulators. J. Braz.Chem. Soc., 1(2005) 6, 1387-1390.
  16. Carnat A. P., Carnat A., Fraisse D. and Lamaison J. LThe aromatic and polyphenolic composition of lemon balm (Melissa officinalis L. Subsp. officinalis tea. Pharma. Acta Helvet., . (1998). 72, 301-305.
  17. Lemon balm (Melissa officinalis), Plant profiler, Sigma-Aldrich.http://sigmaaldrich.com/life/nutrician-research/learning-centre/plant-profiler/Melissa-officinalis.html accessed 19/4.2016.
  18. Ferreira, A., Proenca C., Serralheiro M. L. M. and Araujo. M. E. M The in vitro screening for acetycholinesterase inhibition and antioxidant activity of medicinal plants from Portugal. J. of Ethnopharmacology, . (2006).108, 31-37.
  19. Afifi-Yazar F. U., Kasabri V. and Abu-Dahab R.. Medicinal plants from Jordan in the treatment of cancer: Traditional uses vs. in vitro and in vivo evaluations- part 1. Planta Med. (2011)77, 1203-1209.
  20. Jahanban-Esfahahlan,A., Modaeinama, S., Abasi, M., M. Abbasi, M. M. and Jahanban-Esfahahlan, R. Anti-Proliferative Properties of Melissa officinalis in Different Human Cancer Cells, Asian Pacific J. CancerPrevention,(2015).16, 5703-5707.
  21. Afifi-Yazar F.U., Kasabri V. and Abu-Dahab R. Medicinal Plants from Jordan in the treatment of Diabetes: Traditional uses vs. in vitro and in vivo evaluation- Part2, Planta Med.,. (2011) 77, 1210-1220.
  22. Syouf, Q. M.. In situ conservation of Medicinal plants in Jordan. Medicinal herbal plant project. National Center for Agricultural Research and Extension.(2007)
  23. Clevenger, J. F. Apparatus for the determination of volatile oil. J.Amer. Pharma. Assn.,(1928). 17, 345-349
  24. Adams, R. P., Identification of Essential Oils by Gas Chromatography/Mass Spectroscopy, 4th. Edn., Allured publishing, Carol stream, Illinois, USA.(2012).
  25. Kováts, E. Gas-chromatographische Charaktersierung organischer Verbindungen. Retenionsindices aliphatischer Halogenide, Alkohole, Aldehyde und Ketone Helv. Chim. Acta(1958). 41, 1915-1932.
  26. Van den Dool, H. and Kratz, P .D., A generalization of the retention index system including linear temperature programmed gas-liquid partition chromatography. J. Chromat.,(1963).11, 463-471.
  27. Shalaby, A. S., El-Gengaihi and Khattab MOil of Melissa officinalis L., as affected by storage and herb drying, J. Essent. Oil Res ,(1995) 7, 667-669.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.